El cáncer de pulmón en mujeres

Enriqueta Felip

doi:10.3989/arbor.2015.773n3005

Autores/as

Enriqueta Felip Hospital Universitari Vall d’Hebron

DOI:

https://doi.org/10.3989/arbor.2015.773n3005

Palabras clave:

adenocarcinoma, EGFR, tabaco

Resumen

El cáncer de pulmón es la enfermedad maligna más frecuente en el mundo. En los últimos diez años en España, la mortalidad por cáncer de pulmón ha aumentado un 20% en las mujeres frente a un 5% en los hombres, debido a los cambios recientes de patrones de hábito tabáquico entre ambos sexos. El tabaco sigue siendo la causa única más importante de una enfermedad prevenible en un alto porcentaje de casos. Es muy importante que la población conozca esta realidad y que modifique el estilo de vida, eliminado el tabaquismo, para poder detener esta epidemia que representa el cáncer de pulmón. En este artículo se revisarán aspectos epidemiológicos, así como factores de riesgo, características y pronóstico de las mujeres con cáncer de pulmón, con una especial atención a la población española.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Dogan, S., Shen, R., Ang, D. C., Johnson, M. L., D'Angelo, S. P., Paik, P. K., et al. (2012). Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers. Clinical Cancer Research, 18, 22, pp. 6169-6177. http://dx.doi.org/10.1158/1078-0432.CCR-11-3265

Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W., Comber, H., et al. (2013). Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. European Journal of Cancer, 49, 6, pp. 1374-1403. http://dx.doi.org/10.1016/j.ejca.2012.12.027

Fernández, E., Schiaffino, A., Borras, J. M., Shafey, O., Villalbi, J. R. y La Vecchia, C. (2003). Prevalence of cigarette smoking by birth cohort among males and females in Spain, 1910-1990. European Journal of Cancer Prevention, 12, 1, pp. 57-62. http://dx.doi.org/10.1097/00008469-200302000-00009

Freedman, N. D., Leitzmann, M. F., Hollenbeck, A. R., Schatzkin, A. y Abnet, C. C. (2008). Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncology, 9, 7, pp. 649-656. http://dx.doi.org/10.1016/S1470-2045(08)70154-2

Fu, J. B., Kau, T. Y., Severson, R. K. y Kalemkerian, G. P. (2005). Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database. Chest, 127, 3, pp. 768-777. http://dx.doi.org/10.1378/chest.127.3.768

Henschke, C. I., Yip, R. y Miettinen, O. S. (2006). Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. Journal of the American Association, 296, 2, pp. 180-184. DOI: 296/2/180 [pii]10.1001/jama.296.2.180.

Hsu, L. H., Chu, N. M., Liu, C. C., Tsai, S. Y., You, D. L., Ko, J. S., et al. (2009). Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor? Lung Cancer, 66, 2, pp. 262-267.

Isla, D., Felip, E., Garrido, P., Vinolas, N., Garcia-Campelo, R., Lianes, P., et al. (2007). Sex differences in non-small cell lung cancer (NSCLC) patients (p) participating in Spanish Lung Cancer Group (SLCG) trials. ASCO Meeting Abstracts, 25, 18_suppl, pp. 7679.

Isla, D., Provencio, M., Majem, M., Felip, E., Vinolas, N., Campelo, R. G., et al. (2012). Never-smoking women with lung cancer from the Spanish WORLD07 database. ASCO Meeting Abstracts, 30, 15_suppl, pp. 1531.

Janjigian, Y. Y., McDonnell, K., Kris, M. G., Shen, R., Sima, C. S., Bach, P. B., et al. (2010). Pack-years of cigarette smoking as a prognostic factor in patients with stage IIIB/IV nonsmall cell lung cancer. Cancer, 116, 3, pp. 670-675. http://dx.doi.org/10.1002/cncr.24813

Khuder, S. A. (2001). Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis. Lung Cancer, 31, 2-3, pp. 139-148. http://dx.doi.org/10.1016/S0169-5002(00)00181-1

Li, Q., Dresler, C., Heck, J. E., Allwright, S., Haglund, M., Sanchez, S., et al. (2010). Knowledge and beliefs about smoking and cancer among women in five European countries. Cancer Epidemiology, Biomarkers and Prevention, 19, 11, pp. 2811-2820. http://dx.doi.org/10.1158/1055-9965.EPI-10-0432

Lortet-Tieulent, J., Soerjomataram, I., Ferlay, J., Rutherford, M., Weiderpass, E. y Bray, F. (2014). International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer, 84, 1, pp. 13-22. http://dx.doi.org/10.1016/j.lungcan.2014.01.009

Majem, M., Artal, A., De Castro, J., Felip, E., Garrido Lopez, P., Isla, D., et al. (2012). Population survey to assess the knowledge of smoking habit and its consequences on women (w) in Spain. ASCO Meeting Abstracts, 30, 15_suppl, pp. e12000.

Malvezzi, M., Bertuccio, P., Levi, F., La Vecchia, C. y Negri, E. (2014). European cancer mortality predictions for the year 2014. Annals of Oncology, 25, 8, pp. 1650-1656. http://dx.doi.org/10.1093/annonc/mdu138

Marchetti, A., Felicioni, L., Malatesta, S., Grazia Sciarrotta, M., Guetti, L., Chella, A., et al. (2011). Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations. Journal of Clinical Oncology, 29, 26, pp. 3574-3579. http://dx.doi.org/10.1200/JCO.2011.35.9638

Martínez-Sánchez, J. M., Fernández, E., Fu, M., Gallus, S., Martínez, C., Sureda, X., et al. (2010). Smoking behaviour, involuntary smoking, attitudes towards smoke-free legislations, and tobacco control activities in the European Union. PLoS One, 5, 11, pp. e13881. http://dx.doi.org/10.1371/journal.pone.0013881

Mazieres, J., Peters, S., Lepage, B., Cortot, A. B., Barlesi, F., Beau-Faller, M., et al. (2013a). Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives. Journal of Clinical Oncology, 31, 16, pp. 1997-2003.

Mazieres, J., Rouquette, I., Lepage, B., Milia, J., Brouchet, L., Guibert, N., et al. (2013b). Specificities of lung adenocarcinoma in women who have never smoked. Journal of Thoracic Oncology, 8, 7, pp. 923-929.

Micheli, A., Ciampichini, R., Oberaigner, W., Ciccolallo, L., de Vries, E., Izarzugaza, I., et al. (2009). The advantage of women in cancer survival: an analysis of EUROCARE-4 data. European Journal of Cancer, 45, 6, pp. 1017-1027. http://dx.doi.org/10.1016/j.ejca.2008.11.008

Nakamura, H., Ando, K., Shinmyo, T., Morita, K., Mochizuki, A., Kurimoto, N., et al. (2011). Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis. Annals f Thoracic and Cardiovascular Surgery, 17, 5, pp. 469-480. http://dx.doi.org/10.5761/atcs.oa.10.01637

Ng, M., Freeman, M. K., Fleming, T. D., Robinson, M., Dwyer-Lindgren, L., Thomson, B., et al. (2014). Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. Journal of the American Association, 311, 2, pp. 183-192. http://dx.doi.org/10.1001/jama.2013.284692

Paik, P. K., Johnson, M. L., D'Angelo, S. P., Sima, C. S., Ang, D., Dogan, S., et al. (2012). Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas. Cancer, 118, 23, pp. 5840-5847. http://dx.doi.org/10.1002/cncr.27637

Papadopoulous, A., Guida, F. y Leffondré, K. (2014). Heavy smoking and lung cancer: are women at high risk? Results of ICARE study. British Journal of Cancer, 110, pp. 1358-1391. http://dx.doi.org/10.1038/bjc.2013.821

Radzikowska, E., Glaz, P. y Roszkowski, K. (2002). Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Annals of Oncology, 13, 7, pp. 1087-1093.

Ries, L., Young, J., Keel, G., Eisner, M., Lin, Y. y Horner, M. e. (2007). SEER survival monograph: Cancer survival among adults: US SEER program, 1988-2001: patient and tumor characteristics. NIH publications no 07-6215. Bethesda, MD: National Cancer Institute [en línea]. [Fecha de consulta: julio 2013]. Disponible en: http://seer.cancer.gov/publications/survival/

Rouquette, I., Lauwers-Cances, V., Allera, C., Brouchet, L., Milia, J., Nicaise, Y., et al. (2012). Characteristics of lung cancer in women: importance of hormonal and growth factors. Lung Cancer, 76, 3, pp. 280-285. http://dx.doi.org/10.1016/j.lungcan.2011.11.023

Sagerup, C. M., Smastuen, M. y Johannesen, T. B. (2001). Sex-specific trends in lung cancer incidence and survival: a population study of 40.118 cases. Thorax, 66, pp. 301-307. http://dx.doi.org/10.1136/thx.2010.151621

Salmeron, D., Chirlaque, M. D., Isabel Izarzugaza, M., Sanchez, M. J., Marcos-Gragera, R., Ardanaz, E., et al. (2012). Lung cancer prognosis in Spain: the role of histology, age and sex. Respiratory Medicine, 106, 9, pp. 1301-1308. http://dx.doi.org/10.1016/j.rmed.2012.06.006

Sánchez, M. J., Payer, T., De Angelis, R., Larranaga, N., Capocaccia, R. y Martínez, C. (2010). Cancer incidence and mortality in Spain: estimates and projections for the period 1981-2012. Annals of Oncology, 21, Suppl 3, pp. iii30-36. DOI: mdq090 [pii]10.1093/annonc/mdq090.

Steliarova-Foucher, E., O'Callaghan, M. y Ferlay, J. (2012). European Cancer Observatory: cancer incidence, mortality, prevalence and survival in Europe. Version 1.0. European Network of Cancer Registries, International Agency for Research on Cancer [en línea]. [Fecha de consulta: febrero 2913]. Disponible en: http://eco.iarc.fr.

Torre, L. A., Siegel, R. L., Ward, E. M. y Jemal, A. (2014). International variation in lung cancer mortality rates and trends among women. Cancer Epidemiology, Biomarkers and Prevention, 23, 6, pp. 1025-1036. http://dx.doi.org/10.1158/1055-9965.EPI-13-1220

Wakelee, H. A., Dahlberg, S. E., Brahmer, J. R., Schiller, J. H., Perry, M. C., Langer, C. J., et al. (2012). Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab. Lung Cancer, 76, 3, pp. 410-415. http://dx.doi.org/10.1016/j.lungcan.2011.12.006

Wheatley-Price, P., Blackhall, F., Lee, S. M., Ma, C., Ashcroft, L., Jitlal, M., et al. (2010). The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials. Annals of Oncology, 21, 10, pp. 2023-2028. http://dx.doi.org/10.1093/annonc/mdq067

Zang, E. A. y Wynder, E. L. (1996). Differences in lung cancer risk between men and women: examination of the evidence. Journal of the National Cancer Institute, 88, 3-4, pp. 183-192. http://dx.doi.org/10.1093/jnci/88.3-4.183